The Alliance for Innovation in Maternal Health
Obstetric hemorrhage is the leading cause of maternal morbidity and mortality in the United States and was the cause of 11.5 percent of pregnancy-related deaths between 2011 and 2014. Most deaths associated with maternal hemorrhage are preventable.
Preeclampsia is a condition that occurs only during or shortly after pregnancy and affects both mothers and babies. It can also be referred to as hypertension or high blood pressure. Preeclampsia is also a leading cause of maternal morbidity and mortality in the United States, and reviews of maternal deaths have shown problems with recognition, communication and intervention to prevent harm from the condition.
WHAT WE'RE DOING
Thirty-eight birthing hospitals have signed on to implement the Alliance for Innovation in Maternal Health (AIM) program, which uses evidence-based tools developed by the California Maternal Quality Care Collaborative to improve care, specifically for hemorrhage and preeclampsia.
The AIM program uses a “bundle,” or standardized series of treatments, to reduce the likelihood of harm from hemorrhage or hypertension. The bundle is organized into four “Rs” — Readiness, Recognition & Prevention, Response, and Report.
New Jersey’s labor and delivery hospitals have been implementing the care bundles in their facilities and measuring how much progress is being made. Initial data on the AIM program will be made public when complete.